Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination

BACKGROUND: Activating Transcription Factor (ATF) 3 is a key regulator of the cellular integrated stress response whose expression has also been correlated with pro-apoptotic activities in tumour cell models. Combination treatments with chemotherapeutic drugs, such as cisplatin, and histone deacetyl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: St Germain, Carly, O'Brien, Anna, Dimitroulakos, Jim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2010
Gaiak:
Primary Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2945341/
https://ncbi.nlm.nih.gov/pubmed/20828393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-10-32
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak